Regon Co, Pharmaceuticals
 

FluAWAY Protective Creme

ð   WORLD’s  FIRST  and  ONLY   ï

One of Most Significant Inventions in a Century !

FluAWAYTM Anti-Flu Herbal Remedy Possible Mechanism of Action

 

Review of Pathogens Detected in Patient with Pneumonia Symptoms Manifestation

      Pneumonia is a leading cause of hospitalization worldwide and carries significant morbidity and mortality that differ according to the underlying etiology.[8]

     In general, viral pneumonia is considered less severe compared to bacterial pneumonia. [11]

·  Bacterial pneumonia is a common contributor to severe outcomes of influenza. Epidemiological data suggest that the incidence, severity and associated bacterial pathogens differ between epidemics and by geographical location within epidemics. Data from animal models demonstrate precisely these differences in both viral and bacterial strains alter the incidence and outcomes of pneumonia. For influenza viruses, evolutionary changes (as specific virulence factors) appear to alter the ability of viruses within particular lineages to prime the host for secondary bacterial infection. Although bacterial strains differ considerably in their disease potential for pre-dispositioning of viral co-infection, the bacterial virulence factors underlying this finding are currently unknown. The hypothesis, that geographical variation do exist in the prevalence of bacterial strains expressing factors that enable efficient disease-causing potentiation during viral epidemics, should be considered as one explanation for the regional differences in disease severity. This would have further implications for surveillance, vaccine development, and the conduct of clinical trials for the prevention or treatment of pneumonia.[36]

     The significant role of bacterial co-infection in past pandemics, and in seasonal influenza, has been documented. [11,21.38,40,44] During the 1918–1919 influenza pandemic, the microorganisms most frequently recovered from the sputum, lung and blood of infected patients were Haemophilus influenzae, Streptococcus pneumoniae,  Streptococcus pyogenes and Staphylococcus aureus.[11,38] In most cases, lung samples taken from patients dying during the 1918–1919 pandemic demonstrate bacteriologic and histopathologic evidence of severe acute bacterial pneumonia.[38] During the Asian and Hong Kong influenza pandemics of 1957 and 1968, S. pneumoniae,  H. influenza  and S. aureus were most frequently isolated from patients with bacterial pneumonia. [3,34,40,44] In 1957, S. aureus and  S. pneumoniae were isolated from 59% and 15% of lung cultures, respectively.[21]  Most deaths from S. aureus were observed in adolescents and young adults.

     During the 2009 influenza pandemic, initial clinical descriptions reported a severe respiratory illness with rapid progression to acute respiratory distress syndrome (ARDS).[23] Co-detection of clinically relevant bacteria with influenza A/H1N109 was infrequent, yet 31% of patients admitted to ICU had a clinical diagnosis of sepsis and 95% received antibiotics.[25] Bacterial co-infection was documented using histopathological, immunohistochemical and molecular evidence in 22 of 77 (28·6%) subjects with fatal pandemic influenza A/H1N1 2009 infection. Streptococcus pneumoniae, S. pyogenes  and S. aureus  were the predominant bacterial pathogens detected.

     Bacterial or viral co-infection has complicated one in four patients admitted to ICU with severe influenza A infectionCo-infection was identified in 23·3–26·9% of patients with severe influenza A infection. Staphylococcus aureus infection was the most frequent bacterial co-infection followed by Streptococcus pneumoniae and Haemophilus influenzae. Patients with co-infection were younger [mean difference in age = 8·46 years (95% CI: 0·18–16·74 years)], less likely to have significant co-morbidities (32·0% versus 66·2%, P = 0·004) and less-frequently obese [mean difference in body mass index = 6·86 (95% CI: 1·77–11·96)] compared to those without co-infection – suggesting at increased personal mobility as a possible contributing factor for microbial co-infection; which seems somethat logical consequience. Empiric antibiotics with staphylococcal activity should be strongly considered in all patients with severe influenza A infection.

     Overall, twenty-seven studies including 3215 participants met all inclusion criteria taken from publication data. Common etiologies were defined from a subset of eight articles. There was high heterogeneity in the results (I2 = 95%), with reported coinfection rates ranging from 2% to 65%. The most common coinfecting species were Streptococcus pneumoniae and Staphylococcus aureus, which accounted for 35% (95% CI, 14%56%) and 28% (95% CI, 16% 40%) of infections, respectively; a wide range of other pathogens caused the remaining infections. The frequency of co-infection in the published studies, included in this review, suggests that, although providers should consider possible bacterial coinfection in all patients hospitalized with influenza, they should not assume that all patients are coinfected and ensure to properly treat underlying viral processes. Further, high heterogeneity suggests that additional large-scale studies are needed to better understand the etiology of influenza co-infection with bacteria. [29]

      Researchers from San Diego confirmed that infections with flu virus and with Haemophilus influenzae can be lethal when the flu infection precedes the bacterial one. That was true even for infections that, if experienced separately, would not have been lethal; it was the synergy of the two infections, flu first followed by the bacterial infection, that caused the high mortality rate. In 1968, much of the excess mortality was attributed to the increased incidence of bacterial pneumonia: a three-fold increase in the incidence of staphylococcal pneumonias and strong correlation between staphylococcal pneumonia and prior influenza infection was observed.[44] The results may not be directly applicable to human medicine (Do you all know the old flu-research saying, “Mice lie and ferrets mislead”?), but they are an important indicator of both the seriousness of bacterial infection after flu, and also of the potential vulnerability of even healthy beings to that double-punch[33].

·  Viral pneumonia.   In the past decade the mortality related to Viral pneumonia has substantially increased because of the emergence of the new respiratory viruses such as influenza-A H1N1, the Middle East respiratory syndrome-coronavirus (MERS-CoV) and the Coronavirus Disease of 2019 (COVID-19).[9]   

     Moreover, high mortality was reported in previously healthy middle-aged patients during influenza-A H1N1 pandemic infection in 2009.[35] Reports from the Southern-hemisphere countries suggested that the hospitalization rates secondary to influenza-A H1N1 ranged from 23.6% to 30.6%; among them, 11.7% to 18.5% were admitted to the Intensive Care Units (ICUs) with mortality rate ranged from 16% to 41%.17 Noteworthy, according to the last update from the center for diseases control (CDC) on February 2014, pneumonia and influenza were the cause of death in 8.4% of all deaths in the United States, of which 34% occurred in persons aged ≥65 years, 62% in persons aged 25–64 years, and 4% in persons younger than 24 years old. [13]

     As by July 2017, the World Health Organization (WHO) had received reports from 27 countries of 2040 cases of laboratory-confirmed MERS and at least 677 related deaths representing case fatality of 35%.[52] The course of the disease has been described to vary from asymptomatic viral illness to dramatically fatal respiratory failure and ARDS. Gastrointestinal and renal involvement have also been reported in one-third and one-half of the cases, respectively[2] (Note the high similarity to the COVID-19 infection observations outlined further below). In Saudi Arabia, MERS-CoV virus was first reported in 2012, and between September 1, 2012, and June 15, 2013, there have been 47 laboratory-confirmed cases (46 adults and one child) with a fatality rate of 60%[5]Assiri et al., had reported the epidemiological characteristics of the MERS-CoV in Saudi Arabia either as a community cases running in clusters within the families or among healthcare workers with or without direct camel contacts.[5] During June–August, 2015, a second MERS-CoV outbreak occurred with a total of 130 MERS-CoV cases detected. Overall, 96 patients (74%) required hospitalization, of them 63 (66%) required intensive care management, and the fatality rate was 53%.[7]

     Viral pneumonia remains a major health problem, particularly after emergence of new respiratory viruses, including influenza, and have received more attention compared to other causes of pneumonia after the emergence of the new H1N1 and MERS-CoV.

     The fatality rate was high particularly among cases associated with MERS-COV infection. The most important predictors of death among these patients were old age, male sex, and associated comorbidities. A similar finding was also reported in studies from other Middle-East countries including UAE, Qatar, Oman, Jordan, Kuwait, and Yemen.[10]

     On the contrary, H1N1 influenza pneumonia affects patients at a slightly younger age group.[4,16,15,31]

     It was noted during most pandemics that the age distribution of severe influenza-related pneumonia exhibits a U-shaped pattern, with young and the elderly patients were most frequently affected.[3,45] In this cohort, males were more likely to be infected. This is consistent with a similar finding reported by others[4,10,15,16,30], although a recent report showed more MERS-CoV infection among female healthcare workers.[3]

     The most common radiological finding in this study was bilateral lung infiltrate and that was mostly observed among MERS-CoV (94.1%) and H1N1 (86.7%) associated infections.

     The pattern of interstitial infiltrates with patchy distribution on chest radiograph was sometimes useful in differentiating viral from bacterial community-acquired pneumonia.[48] These specifics, however, were not universal. Similarly, the presence of pleural effusion predicts bacterial infection,[22] and that has not been reported in any of the studied cases.

 

·  Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat.[56] No effective treatment has yet been established and severe morbidity and mortality have been reported to be higher in the elderly and patients with underlying diseases.[32] COVID-19 often starts with non-specific upper respiratory tract symptoms, making it difficult to distinguish from those of other diseases.[9] In particular, influenza virus infections may present similar symptoms as those of COVID-19. The current lack of clinical knowledge about COVID-19 might, therefore, lead to bias and missed diagnoses in cases of co-existing infections. In one hospital, was encountered a case of influenza A virus and SARS-CoV-2 co-infection, which allowed to analyze the overlapping clinical course of these two viral infections.[47]

     COVID-19 and Influenza co-infection can occur in patients and can present with similar symptoms.[6,28,30,41,49,53,54]  It is essential to recognize the co-infections as some can be treated with antibiotics and antivirals. We already have treatments for influenza, but while multiple drugs are being investigated for COVID-19, none have been approved for treatment so far.

     COVID-19 can initially present with minor symptoms such as fever with or without chills, dry cough, shortness of breath, fatigue, muscle aches, sore throat, confusion, headache and rhinorrhea. The lung is the main organ affected, which can result in respiratory failure. The disease can also present with atypical symptoms such as nausea, vomiting and diarrhea.[8]

     Influenza in the USA occurs mainly during winter, and the burden of disease is determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. According to CDC estimates, during the 2018–2019 season symptomatic influenza occurred in approximately 35 million patients[26], which resulted in approximately 16 million hospital visits and approximately 500,000 hospitalizations with 34,000 deaths[14]. The most common symptoms of influenza are fever, cough, shortness of breath, fatigue, headache, myalgia and arthralgia, similar to those of COVID-19.

     COVID-19 can simultaneously present with other infections such as influenza, and it can be hard to distinguish the symptoms of the two conditions from each other. However, there are differences and these are summarized in Table 3.[8] A study by Xing et al. analyzed common respiratory pathogens presenting as co-infections with COVID-19 from Quingdao and Wuhan. This report identified IgM antibodies to at least one respiratory pathogen in 80% and 2.6% of the patients from Quingdao and Wuhan, respectively. Influenza A, influenza B, followed by Mycoplasma and Legionella, were the most common respiratory pathogens detected.[55]

     In a study from Wuhan, five of 115 patients were co-infected with COVID-19 and influenza. Most of these patients presented with fever, cough and shortness of breath. All of the co-infected patients presented with pharyngeal pain. Only one of the co-infected patients developed acute respiratory distress syndrome and required non-invasive ventilation.

     Finally, routine testing for newly emergent viruses may be warranted for adults who have been hospitalized with pneumonia.

 

Table 1. Differences between influenza and COVID-19 diseases.

 

Influenza

COVID-19

Asymptomatic or symptomatic

Patients can be asymptomatic due to herd immunity

Most patients develop symptoms within 2 days of infection

Viral shedding

5–10 days

Up to 14 days or even longer

Severity of illness

Majority of infections are mild to moderate

Severe illness can occur

Mortality

Less than 1%

3–4%

Vaccines

Vaccines available; efficacy varies from season to season

No vaccine available, clinical trials in progress

Treatment

Oseltamivir
Zanamivir
Peramivir
Baloxavir

No treatment available, clinical trials in progress

Acute respiratory distress syndrome

Less common

More common

 

 

FluAWAYTM Possible Mechanism of Action

The mechanism by which FluAWAYTM eliminates the cold/pheumonia symptoms is still unknown. Since lipid-based communication and trans-membrane signaling is the first evolutionary mean of communication among species, we speculate that FluAWAYTM component(s) affects (reduce or modify) the cell receptors to which the cold- and pneumonia-causing viruses and/or microbes attaches to invade the body; or somehow, in addition, it assists the immune system in eliminating the infection – since the cold/pneumonia disease is generally caused by simultaneous multi-microbial and multi-viral co-infection. We favor the first hypothesis due to the instant effect observed after FluAWAYTM application while assisting the immune system may play role at the later stages of disease elimination.

It is well-known that the cell membrane provides a reservoir from which biologically active signaling lipids, or their precursors, are released by a variety of hydrolytic enzymes. Research has shown, that lipidtransfer proteins are capable of influencing the outcome of host–pathogen interactions. Lipid modifications target signaling proteins and microbial elicitors to cell membranes where defense signaling is initiated.[27] Another class of biologically active compounds, flavonoids are metabolites synthesized mainly by plants. They can act as chemical messengers, physiological regulators, and cell cycle inhibitors. Laboratory studies indicate that flavonoids have effects on isolated cells or cell cultures in vitro and have been shown in preliminary research to have anti-inflammatory mechanisms including inhibition of gene transcription, expression and activity of inflammatory enzymes, as well as secretion of anti-inflammatory mediators.[61] The plants with flavonoids as their major constituents, for example, can inhibit Helicobacter pylori infection and are used as anti-peptic ulcer disease.[62] Flavonoids have also been implicated to modify intracellular signaling pathways in immune cells,[63] or in brain cells after a stroke.[64]

Another reasonable hypothesis speculates, that, because the nose is the normal ecological location where both non-pathogenic and pathogenic strains of microbes like Streptococcus reside normally[37], the application of FluAWAYTM inside the nose bringing plant-derived ani-microbial substances serves as a straight-to-the-source cut-off factor preventing the spread of the human pathogens wide inside the body. The immediate relief action resulting from the application of FluAWAYTM inside the nose supports this hypothesis.[60]

Our tests over a 10-year period show that FluAWAYTM acts in a different way than the antibiotics. For example: The flu invasion usually manifests its symptoms starting from the nose, then moving to the throat, and then – the lungs and the entire body. The antibiotic-mediated relieve-symptoms manifest the same way: relieving first the nose, then the throat and the entire body at last. The FluAWAYTM, however, relieves the lungs first (while initially easing the nose-affecting symptoms), then the throat and at last completely removing the nose irritation.

  

How to apply FluAWAYTM creme

Place FluAWAYTM creme amount equal to the size of pea-bean on the top of a cotton-swab stick or the back of a finger nail. Introduce it high-up into each nozzle cavity and apply it evenly up there. Breed-in sharply by closing the opposite nozzle to depose the creme high into the sinuses. Incidental swallowing it is of no concern – in fact the remedy (prepared as a solution) can also be used to calm stomach infections and cases of diarrhea. 

At best, we recommend to use FluAWAYTM immediately after the occurrence of the first cold/pneumonia symptoms. This provides for fastest prevention of the infection with introducing tiniest amounts of the crème; if so – no flu infection will further develop in person’s body. Depending on the stage of infection and the personal specifics, the flu-symptoms elimination may be as fast as 1-2 applications and within few hours only (overnight application is highly recommended), or to take up to 3 days. Although FluAWAYTM may be used for up to 5 days or more, if desired, usually 3 days with 3-5 daily applications are enough for most people to eliminate the pneumonia symptoms. In severe cases, FluAWAYTM crème can be applied every hour during the first day, but usually no such a frequent application is needed after 24 hours of use. However, in cases of Covid-19 or similar coronavirus infection treatment, we strongly recommend hourly nasal applications until diminished symptomatic is achieved completely.

When FluAWAYTM is applied before meetings in a closed space with peoples (possible) already having a flu – no single case of catching a flu out of hundreds of occasions has been observed previously.

NOTE, that we have no data on how FluAWAYTM usage may affect pregnancy or infants. Although side-effects were never detected and are not expected due to the negligible herbal amounts deposited, allergy effects might be possible. Therefore, as a precaution, we recommend allergy skin test to be performed for 24 hours before using FluAWAYTM for a first time.

 

Review of Bio-Communication Pathways in Human and animals

Lipids are not just used as a passive component of membranes, or as a source of stored energy. They are involved in the process of signal transduction at the cell membrane, a process by which the interior components of the cell respond to a signal external to the cell, allowing the cell to respond to their local environment. Usually a chemical signal on the outside of the cell is the "primary messenger" that causes the cell to respond. Normally the chemical transmitter of information does not get into the cell. Rather it binds to surface receptors on the cell membrane surface. Somehow, the cells senses that a ligand is bound to the outside. Enzymes within the membrane or at the intracellular surface of the membrane lipid bilayer are activated. Many of these enzymes cleave lipids located in the membrane. The cleaved fragments of the lipid molecules then serve as intracellular signals or "secondary messengers", which can bind to intracellular enzymes to activate intracellular processes. The following diagram (Fig. 1) shows some of the lipid mediators which are generated by the process and signal the cell to respond. These are the bio-informational pathways served by lipid-associated functions:

·   Lipids act as extracellular and intracellular messengers to control cell fate in normal physiology and disease. When deregulated, lipid signaling contributes to inflammation and cancer, metabolic, cardiovascular (blood pressure, etc.) and degenerative disease.

·   Signals such as growth factors, cytokines and chemokines, but also constituents of nutrients, modulate the activity of lipid-modifying enzymes: phosphoinositide 3-kinase (PI3K), sphingosine kinase (SphK), phospholipase C (PLC) and PLD function upstream of the activation of phospholipase A2 (PLA2), prostaglandin H2 synthase (PGH2S) and 5-lipoxygenase (5-LO), which are required for eicosanoid release.

·   Eicosanoids such as prostaglandins and leukotrienes have been known to have a role in inflammation. Recently, their extracellular action on G protein-coupled receptors (GPCRs) has been deciphered, and intracellular binding partners of eicosanoids have also been identified, which opens new possibilities for more selective drug-targeting strategies in inflammation and cancer.

·   Inflammation and cancer are both characterized by excess activation of PI3K and SphK pathways, which enforces growth-factor-receptor signaling, cell growth and survival, cell motility and degranulation. This overrides the pro-apoptotic actions of ceramide and sphingosine.

·   Although the nutritional energy supply normally increases insulin and lipid signaling through PI3K, excess circulating fatty acids induce long-term insulin resistance and function as pro-inflammatory agents. This occurs through signaling via the Toll-like receptor TLR4 and through endoplasmic reticulum stress promoted by intracellular lipid accumulation. It results in the production of reactive oxygen species and the activation of inflammatory kinase pathways (PKC, IKKβ), terminating the relay of signals through insulin receptor substrate (IRS).

·   Lipid-modifying enzymes, pathways and their downstream targets, including nuclear receptors and lipid-binding proteins, form a complex signaling network. Although many of these lipid mediators emerge from the same membranes, they are usually studied in isolation. Here, we present an integrated overview of lipid signaling in disease and highlight nodes of lipid signaling pathway interaction, and discuss emerging strategies for therapeutic interventions.

·   Steroids are another class of lipid molecules, identifiable by their structure of four fused rings. Although they do not resemble the other lipids structurally,  steroids are included in lipid category because they are also hydrophobic and insoluble in water. Recently, steroids from starfish (similar to bile acids in the human stomach) tested against normal mouse epidermal, human breast cancer and colorectal carcinoma cells, the steroids were demonstrated to have a pronounced anticancer effect.[59]  Another recent report evidences that glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.[60]

pheromone is a secreted or excreted chemical factor that triggers a social response in members of the same species and/or across species.  Pheromones are chemicals capable of acting like hormones outside the body of the secreting individual, to impact the behavior of the receiving individuals. There are alarm pheromonesfood trail pheromonessex pheromones, and many others that affect behavior or physiology.

Pheromones are used from basic unicellular prokaryotes to complex multicellular  eukaryotes. Their use among insects has been particularly well documented. In addition, some vertebrates, plants and ciliates communicate by using pheromones. Pheromones are also sometimes classified as ecto-hormones. These chemical messengers are transported outside of the body and affect neurocircuits, including the autonomous nervous system with hormone or cytokine-mediated  physiological changes, inflammatory signaling, immune system changes and/or behavioral change in the recipient.

In reptilesamphibia and non-primate mammals pheromones are detected by regular olfactory membranes, and also by the vomeronasal organ (VNO), or Jacobson's organ, which lies at the base of the nasal septum between the nose and mouth and is the first stage of the accessory olfactory system. While the VNO is present in most amphibia, reptiles, and non-primate mammals, it is absent in birds, adult catarrhine monkeys (downward facing nostrils, as opposed to sideways), and apes. An active role for the human VNO in the detection of pheromones is disputed; while it is clearly present in the fetus it appears to be atrophied, shrunk or completely absent in adults. Nevertheless, the VNO is only one way of detecting intra-species signaling – others are the direct delivery into the body via skin- and nasal pathways wherefrom they can enter the internal body communication transport network being deposited into the cerebral liquid, blood and lymph and be delivered to their cellular target where they exercise their molecular communication purpose.

Practically in all species, the pheromones are associated with a lipid molecular content in order to become a biologically active substance – steroids, aliphatic acids, lipidic function-stimulators and others. Thereby all inter-cellular and inter-species signaling and communications are based upon lipid (i.e. fatty-acids) molecular association and assistance.

Recently, fatty acid amides have been shown to be potent mediators of neurological processes.[57] In one interesting experiment, sheep were sleep deprived. Reasoning that the brain might release a biochemical signal into cerebrospinal fluid to induce sleep, scientists at Scripps removed some of this fluid and isolated a substance that was not found in rested sheep. On analysis, the structure was shown to be an amide of oleic acid. Oleylethanolamide has been shown to bind to the peroxisome-proliferator-activated receptor-a (PPAR-a) which resides in the nucleus. This ligand, by affecting gene transcription, appears to regulate body weight and the feeling of fullness after eating (satiety) as it leads to reduced eating.

 In an analogous fashion, people have sought the natural neurotransmitter, which binds to the same receptor in the brain as THC, the active ingredient of marijuana. This was found several years ago and was shown to be the amide of arachidonic acid, called anandamide.

   

Figure 1: Lipid Signaling in disease

  

1.6: Lipids and Signaling - Biology LibreTexts

 

 

 

 

 

 

 

 

 

 

 

 

 

 Figure 2: Lipids - Mediators in Signal Transduction

  

 

 

 

 

 

 

   Figure 3: Schematic representation of the Glyce-rophosphoinositols metabolism (from: Patrussi, L., Mariggiò, S., Corda, D and Baldari, C.T. The glycerol- phosphoinositols: from lipid metabolites to modulators of T-cell signaling. Front. Immunol., 29 July 2013| (https://doi.org/10.3389/fimmu.2013.00213)

 

·   Another class of biologically active compounds, flavonoids are metabolites synthesized mainly by plants. The general structure of flavonoids is a 15-carbon skeleton, containing 2 benzene rings connected by a 3-carbon linking chain. They can act as chemical messengers, physiological regulators, and cell cycle inhibitors. Laboratory studies indicate that flavonoids have effects on isolated cells or cell cultures in vitro. Inflammation has been implicated as a possible origin of numerous local and systemic diseases, and flavonoids have been shown in preliminary research to have anti-inflammatory mechanisms including inhibition of gene transcription, expression and activity of inflammatory enzymes, as well as secretion of anti-inflammatory mediators.[61] The plants with flavonoids as their major constituents, for example, can inhibit Helicobacter pylori infection and are used as anti-peptic ulcer disease. [62] Flavonoids have also been implicated to modify intracellular signaling pathways in immune cells,[63] or in brain cells after a stroke.[64]

 

Review of Microbial and Plant Communication Pathways

The yeast Saccharomyces cerevisiae produces pheromones (that have strong similarities to peptide hormones in mammals) which seem to participate in the mating process by binding to cell receptors

But in the early 1980s, the University of Washington zoologist David Rhoades was finding evidence that plants actively defend themselves against insects. Masters of synthetic biochemistry, they manufacture and deploy chemical and other weapons that make their foliage less palatable or nutritious, so that hungry bugs go elsewhere.

Plant Pheromones are chemicals released by an organism into its environment enabling it to communicate with other members of its own species. There are alarm pheromones, food trail pheromones, sex pheromones, and many others that affect behavior or physiology.

Plant semiochemicals are known to produce a wide range of behavioral responses in insects. Some insects sequester or acquire host plant compounds and use them as sex pheromones or sex pheromone precursors. Other insects produce or release sex pheromones in response to specific host plant cues, and chemicals from host plants often synergistically enhance the response of an insect to sex pheromones. Plant volatiles can also have inhibitory or repellent effects that interrupt insect responses to pheromones and attract predators and parasitoids to the attacking species after herbivory injury.

Green leaf volatiles interrupt aggregation pheromone response in bark infesting pines.

It’s now well established that when bugs chew leaves, plants respond by releasing volatile organic compounds into the air.

Accoding to Richard Karban, an ecologist at the University of California, Davis, 40 out of 48 studies of plant communication confirm that other plants detect these airborne signals and ramp up their production of chemical weapons or other defense mechanisms in response. “The evidence that plants release volatiles when damaged by herbivores is as sure as something in science can be,” said Martin Heil, an ecologist at the Mexican research institute Cinvestav Irapuato. “The evidence that plants can somehow perceive these volatiles and respond with a defense response is also very good.”

More broadly, the possibility that plants share information raises intriguing questions about what counts as behavior and communication — and why organisms that compete with one another might also see fit to network their knowledge.

Scientists are also exploring how the messages from these signals might spread. Just a few months ago, the plant signaling pioneer Ted Farmer of the University of Lausanne discovered an almost entirely unrecognized way that plants transmit information — with electrical pulses and a system of voltage-based signaling that is eerily reminiscent of the animal nervous system. “It’s pretty spectacular what plants do,” said Farmer. “The more I work on them, the more I’m amazed.”

Ted Farmer’s team placed microelectrodes on the leaves and leaf stalks of Arabidopsis thaliana (a model organism, the plant physiologist’s equivalent of a lab rat) and allowed Egyptian cotton leafworms to feast away. Within seconds, voltage changes in the tissue radiated out from the site of damage toward the stem and beyond. As the waves surged outward, the defensive compound jasmonic acid accumulated, even far from the site of damage. The genes involved in transmitting the electrical signal produce channels in a membrane just inside the plant’s cell walls; the channels maintain electrical potential by regulating the passage of charged ions. These genes are evolutionary analogues to the ion-regulating receptors that animals use to relay sensory signals through the body. “They obviously come from a common ancestor, and are deeply rooted,” Farmer said. “There are lots of interesting parallels. There are far more parallels than differences.”

Ted Farmer, then a postdoc in the Washington State University lab of renowned plant hormone expert Clarence Ryan. Farmer and Ryan worked with local sagebrush, which produce copious amounts of methyl jasmonate, an airborne organic chemical that Ryan thought plants were using to ward off insect herbivores. In their experiment, when damaged sagebrush leaves were put into airtight jars with potted tomato plants, the tomatoes began producing proteinase inhibitors — compounds that harm insects by disrupting their digestion. Interplant communication is real, they said in a 1990 paper[18] “If such signaling is widespread in nature it could have profound ecological significance.”

During the next decade, evidence grew. It turns out almost every green plant that’s been studied releases its own cocktail of volatile chemicals, and many species register and respond to these plumes. For example, the smell of cut grass — a blend of alcohols, aldehydes, ketones and esters — may be pleasant to us but to plants signals danger on the way. Heil has found that when wild-growing lima beans are exposed to volatiles from other lima bean plants being eaten by beetles, they grow faster and resist attack. Compounds released from damaged plants prime the defenses of corn seedlings, so that they later mount a more effective counterattack against beet armyworms. These signals seem to be a universal language: sagebrush induces responses in tobacco; chili peppers and lima beans respond to cucumber emissions, too.

Plants can communicate with insects as well, sending airborne messages that act as distress signals to predatory insects that kill herbivores. Maize attacked by beet armyworms releases a cloud of volatile chemicals that attracts wasps to lay eggs in the caterpillars’ bodies. The emerging picture is that plant-eating bugs, and the insects that feed on them, live in a world we can barely imagine, perfumed by clouds of chemicals rich in information. Ants, microbes, moths, even hummingbirds and tortoises (Farmer) all detect and react to these blasts.

Rather than using the vascular system to send messages across meters-long distances, maybe plants release volatile chemicals as a faster, smarter way to communicate with themselves. Other plants can then monitor these puffs of airborne data. Bolstering this theory, most of these chemical signals seem to travel no more than 50 to 100 centimeters, at which range a plant would mostly be signaling itself.

Lipids influence multiple stages of plant–pathogen interactions including communication between the host and the microbe, activation and implementation of plant defenses, and the pathogen life cycle[46]. Some pathogens recognize plant lipid‐derived signals to identify an appropriate host. Other pathogens depend on the host for lipids as essential molecules or as developmental signals. In contrast, plants have evolved mechanisms to recognize microbial lipids and this can lead to elicitation of defense responses. In several cases, lipid modifications target plant signaling proteins and microbial elicitors to plant cell membranes where defense signaling is initiated. The membrane also provides a reservoir from which biologically active signaling lipids, or their precursors, are released by a variety of hydrolytic enzymes. A large number of lipid‐modifying enzymes are involved in the synthesis of signaling lipids. This chapter focuses on progress made in recent years on lipids, lipid signaling, lipid‐modifying enzymes and lipid‐transfer proteins that influence the outcome of plant–pathogen interactions.[46]

Parts of the signal transduction pathway for lipid remodeling have been studied[12,24,22,48]. However, detailed metabolite analysis regarding lipid remodeling has been limited. Previous studies have thus far focused only on several well-known lipid classes[58] because of the difficulties associated with the comprehensive analysis of plant lipids, which consist of a wide variety of hydrophobic chemicals. In this study, we applied untargeted metabolomic analysis, which allows comprehensive chemical metabolic phenotyping of cells,

Plant lipid droplets are found in seeds and in post-embryonic tissues. Lipid droplets in seeds have been intensively studied, but those in post-embryonic tissues are less well characterized. Although known by a variety of names, here we will refer to all of them as lipid bodies (LBs). LBs are unique spherical organelles which bud off from the endoplasmic reticulum, and are composed of a single phospholipid (PL) layer enclosing a core of triacylglycerides. Although initially viewed as simple stores for energy and carbon, the emerging view is that LBs also function in cytoplasmic signaling, with the minor LB proteins caleosin and steroleosin in a prominent role. They appear to function in dormancy release by reconstituting cell-cell signaling paths.

Most land plants are able to form partnerships with certain fungi – known as arbuscular mycorrhiza fungi – that live in the soil[27].To exchange nutrients, the fungi grow into the roots of the plant and form highly branched structures known as arbuscules inside plant cells. Due to the difficulties of studying this partnership, it has long been believed that plants only provide sugars to the fungus. However, it has recently been discovered that these fungi lack important genes required to make molecules known as fatty acids. Therefore, these results raise the possibility that the plant may provide the fungus with some of the fatty acids the fungus needs to grow and the plant-fungi communications are governed via small lipid signaling molecules.

References

 1Al Mazroa MA, Memish ZA, AlWadey AM. Pandemic influenza A(H1N1) in Saudi Arabia: Description of the first one hundred cases. Ann Saudi Med. 2010;30:11–4. [PMC free article] [PubMed[Google Scholar]

2.  Alraddadi BM, Watson JT, Almarashi A, Abedi GR, Turkistani A, Sadran M, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22:49–55. [PMC free article] [PubMed[Google Scholar]

3.  Alsahafi AJ, Cheng AC. The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015. Int J Infect Dis. 2016;45:1–4. [PMC free article] [PubMed[Google Scholar]

4Appuhamy RD, Beard FH, Phung HN, Selvey CE, Birrell FA, Culleton TH, et al. The changing phases of pandemic (H1N1) 2009 in Queensland: An overview of public health actions and epidemiology. Med J Aust. 2010;192:94–7. [PubMed[Google Scholar]

5Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis. 2013;13:752–61. [PMC free article] [PubMed[Google Scholar]

6.  Azekawa S, Namkoong H, Mitamura K, Kawaoka Y, Saito F. Co-infection with SARS-CoV-2 and influenza A virus. IDCases. 2020 Apr 21;20:e00775. doi: 10.1016/j.idcr.2020.e00775. eCollection 2020.PMID: 32368495 Free PMC article.

7Balkhy HH, Alenazi TH, Alshamrani MM, Baffoe-Bonnie H, Arabi Y, Hijazi R, et al. Description of a hospital outbreak of middle east respiratory syndrome in a large tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol. 2016;37:1147–55. [PMC free article] [PubMed[Google Scholar]

8. Balla M, Merugu GP, Patel M, Koduri NM, Gayam V, Adapa S, et al. COVID-19, modern pandemic: a systematic review from a front-line health care providers’ perspective. J Clin Med Res 2020;12(4):215–229.

9. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region case series. N Engl J Med 2020, doi:http://dx.doi.org/10.1056/NEJMoa2004500.

10Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, et al. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-coV) infection in the United States, updated information on the epidemiology of MERS-coV infection, and guidance for the public, clinicians, and public health authorities – May 2014. MMWR Morb Mortal Wkly Rep. 2014;63:431–6. [PMC free article] [PubMed[Google Scholar]

11. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918–19 influenza pandemic. Emerg Infect Dis 2008; 14:11931199. CrossRef | PubMed | Web of Science® Times Cited: 118

12. Byers J.A. Pheromone biosynthesis in the bark beetle, Ips paraconfusus, during feeding or exposure to vapors of host plant precursors. Insect Biochem. 1981; 11563-569  View in Article | Scopus (65) | Crossref | Google Scholar

13Centers for Disease Control and Prevention. [Last accessed on 2017 Feb 21];CDC Health Update: Swine Influenza A(H1N1) Update: Influenza Activity- United States. Centers for Disease Control and Prevention; 29 September, 8 February, 2013. 2014 [Google Scholar]

14.  Centers for Disease Control and Prevention. Influenza (Flu). Available from https://www.cdc.gov/flu/about/burden/index.html (accessed 11 April 2020).

15. Dee S, Jayathissa S. Clinical and epidemiological characteristics of the hospitalised patients due to pandemic H1N1 2009 viral infection: Experience at Hutt hospital, New Zealand. N Z Med J. 2010;123:45–53. [PubMed[Google Scholar]

16. Delaney JW, Fowler RA. 2009 influenza A(H1N1): A clinical review. Hosp Pract (1995) 2010;38:74–81. [PubMed[Google Scholar]

17. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302:1880–7. [PubMed[Google Scholar]

18. Farmer, E.E. and Ryan, C.A. Interplant communication: airborne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves.

https://doi.org/10.1073/pnas.87.19.7713

19File TM. Community-acquired pneumonia. Lancet. 2003;362:1991–2001. [PMC free article] [PubMed[Google Scholar]

20Galván JM, Rajas O, Aspa J. Review of non-bacterial infections in respiratory medicine: Viral pneumonia. Arch Bronconeumol. 2015;51:590–7. [PMC free article] [PubMed[Google Scholar]

21García-García ML, Calvo C, Pozo F, Villadangos PA, Pérez-Breña P, Casas I, et al. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J. 2012;31:808–13. [PubMed[Google Scholar]

20Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25–44. [PubMed[Google Scholar]

21. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958; 2:11411143.

CrossRef | PubMed | CAS | Web of Science® Times Cited: 126

22. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 1990; 343425-430  View in Article | Scopus (4156) | PubMed | Crossref | Google Scholar

23. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009; 84:185189. PubMed

24. Hunt D.W.A. et al. Sex-specific production of ipsdienol and myrcenol by Dendroctonus ponderosae (Coleoptera: Scolytidae) exposed to myrcene vapors. J. Chem. Ecol. 1986; 121579-1586  View in Article | Scopus (33) | PubMed | Crossref | Google Scholar

25. Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009; 361:19351944. CrossRef |  PubMed | CAS | Web of Science® Times Cited: 751

26. John Hopkins University of Medicine Coronavirus Resource Center. Available from https://coronavirus.jhu.edu/map.html (accessed 11 April 2020).

27. Keymer A., Pimprikar P., Wewer V., Huber C., Brands M., Bucerius S.L. ,  Delaux P.-M., Klingl V., von Röpenack-Lahaye E., Wang T.L., Eisenreich W., Dörmann P., Parniske M., Gutjahr C. Lipid transfer from plants to arbuscular fungi. eLife 2017;6:e29107 DOI: 10.7554/eLife.29107    https://elifesciences.org/articles/29107

28. Khodamoradi Z, Moghadami M, Lotfi M.Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. Arch Iran Med. 2020 Apr 1; 23(4):239-243. doi: 10.34172/aim.2020.04.PMID: 32271596

29. Klein et al. (2016) The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza and Other Respiratory Viruses 10(5), 394403

30.  Konala VM, Adapa S, Gayam V, Naramala S, Duggubati SR, Kammari CB, Chenna A. Co-infection with influenza A and COVID-19. EJCRIM 2020; 7: doi:10.12890/2020_001656.

31. Lan YC, Su MC, Chen CH, Huang SH, Chen WL, Tien N, et al. Epidemiology of pandemic influenza A/H1N1 virus during 2009-2010 in Taiwan. Virus Res. 2013; 177:46–54. [PubMed[Google Scholar]

32. Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan. Clin Infect Dis 2020, doi:http://dx.doi.org/10.1093/cid/ciaa242 pii: ciaa242.

33. Lee L.N., Dias P., Han D., et al.: A mouse model of lethal synergism between influenza virus and Haemophilus influenzaeAm J Pathol 176: 800-811

34. Lindsay MI Jr, Herrmann EC Jr, Morrow GW Jr, Brown AL Jr. Hong Kong influenza: clinical, microbiologic, and pathologic features in 127 cases. JAMA 1970; 214:18251832.  CrossRef | PubMed | Web of Science® Times Cited: 74

35Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896–902. [PubMed[Google Scholar]

36. McCullers, J. A. Do specific virus–bacteria pairings drive clinical outcomes of pneumonia? Microbiology and Infection, volume 19, Issue 2 (2013), pp 113–118

37.  Minhas V.Harvey R.M.McAllister L.J.Seemann T., Syme A. E.Baines S. L., Paton J. C.Trappetti C. Capacity To Utilize Raffinose Dictates Pneumococcal Disease Phenotype. MBIO, e02596-18 |  DOI: 10.1128/mBio.02596-18 |  https://mbio.asm.org/content/10/1/e02596-18

38. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962970.  CrossRef | PubMed | Web of Science® Times Cited: 306

39Novel Swine-Origin Influenza A(H1N1) Virus Investigation Team. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med. 2009;360:2605–15. [PubMed[Google Scholar]

40. Petersdorf RG, Fusco JJ, Harter DH, Albrink WS. Pulmonary infections complicating Asian influenza. AMA Arch Intern Med 1959; 103:262272. CrossRef | PubMed | CAS | Web of Science® Times Cited: 64

 41. Rodriguez JA, Rubio-Gomez H, Roa AA, Miller N, Eckardt PA. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report. IDCases. 2020 Apr 20;20:e00762. doi: 10.1016/j.idcr.2020.e00762. eCollection 2020.PMID: 32368493 Free PMC article.

42. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377:1264–75. [PMC free article] [PubMed[Google Scholar]

43. Sangil A, Calbo E, Robles A, Benet S, Viladot ME, Pascual V, et al. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: The role of respiratory viruses. Eur J Clin Microbiol Infect Dis. 2012;31:2765–72. [PMC free article] [PubMed[Google Scholar]

44. Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med 1971; 127:10371041. CrossRef | PubMed | CAS | Web of Science® Times Cited: 202

45Serfling RE, Sherman IL, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. Am J Epidemiol. 1967;86:433–41. [PubMed[Google Scholar]

46. Shah J., Chaturvedi R. 10 Lipid Signals in Plant–Pathogen Interactions. Annual Plant Reviews book series, (2018) Volume 34: Molecular Aspects of Plant Disease Resistance. https://doi.org/10.1002/9781119312994.apr0370

47. Shuhei Azekawa, Ho Namkoong, Keiko Mitamura, Yoshihiro Kawaoka, Fumitake Saito Co-infection with SARS-CoV-2 and influenza A virus. IDCases, Volume 20, 2020, e00775;  https://doi.org/10.1016/j.idcr.2020.e00775

48. Tittiger C. et al. Structure and juvenile hormone-mediated regulation of the HMG-CoA reductase gene from the Jeffrey pine beetle, Dendroctonus jeffreyi. Mol. Cell. Endocrinol. 2003; 19911-21  View in Article | Scopus (42) | PubMed | Crossref | Google Scholar

49. Touzard-Romo F, Tapé C, Lonks JR. Co-infection with SARS-CoV-2 and Human Metapneumovirus. R I Med J (2013). 2020 Mar 19;103(2):75-76.PMID: 32192233

50World Health Organization. “Acute Respiratory Update”. [Last accessed on 2017 Feb 21]. Available from: http://www.who.int/vac-Cine_Research/diseases/ari/en/index5 .

51. World Health Organization. Distribution of Con- Firmed Cases of Influenza A(H1N1) by Age. WHO European Region. [Last accessed on 2009 Apr/May]. Available from: http://www.euro.who.int/influenza/AH1N0090508_5 .

52World Health Organization. Middle East respiratory Syndrome Coronavirus (MERS-CoV) [Last accessed on 2017 Feb 21]. Available from: http://www.who.int/emergencies/mers-cov/en .

53. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Wu D, Lu J, Ma X, Liu Q, Wang D, Gu Y, Li Y, He W. Pediatr Infect Dis J. 2020 Jun;39(6):e79.  doi: 10.1097/INF.0000000000002688.PMID: 32287051 Free PMC article. 

54. Wu X, Cai Y, Huang X, Yu X, Zhao L, Wang F, et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis. 2020;26(6):1324-1326. https://dx.doi.org/10.3201/eid2606.200299

55. Xing Q, Li GJ, Xing YH, Chen T, Li WJ, Ni W, et al. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. Available from http://dx.doi. org/10.2139/ssrn.3550013 (accessed 17 April 2020).

56. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):105462, doi:http://dx.doi.org/10.1016/ S0140-6736(20)30566-3.

57. https://bio.libretexts.org/Bookshelves/Biochemistry/Book%3A_Biochemistry_Online_  (Jakubowski)/01%3A_LIPID_STRUCTURE/1.6%3A_Lipids_and_Signaling

58. Dickens J.C. Green leaf volatiles enhance aggregation pheromone of the boll weevil Anthonomus grandis. Entomol. Exp. appl. 1989; 52191-203  View in Article | Scopus (99)  | Crossref | Google Scholar

59. Malyarenko TV, Kicha AA, Malyarenko OS et al. New conjugates of polyhydroxysteroids with long-chain fatty acids from the deep-water far eastern starfish Ceramaster patagonicus and their anticancer activity. Mar. Drugs 18(5), 260 (2020).

60. H. Clifford Lane, Anthony S. Fauci. (2020) Research in the Context of a Pandemic. N Engl J Med.  July 17, 2020; DOI: 10.1056/NEJMoa2021436

61. Martinez-Micaelo N, González-Abuín N, Ardèvol A, Pinent M, Blay MT (2012). "Procyanidins and inflammation: Molecular targets and health implications". BioFactors38 (4): 257–265. doi:10.1002/biof.1019PMID 22505223

62. Ardalani, Hamidreza; Hadipanah, Amin; Sahebkar, Amirhossein (27 December 2019). "Medicinal plants in the treatment of peptic ulcer disease: A review". Mini-Reviews in Medicinal Chemistry. 20 (8): 662–702. doi:10.2174/1389557520666191227151939PMID 31880244.

63. Izzi V, Masuelli L, Tresoldi I, Sacchetti P, Modesti A, Galvano F, Bei R (2012). "The effects of dietary flavonoids on the regulation of redox inflammatory networks". Frontiers in Bioscience17 (7): 2396–2418. doi:10.2741/4061PMID 22652788

64. Gomes A, Couto D, Alves A, Dias I, Freitas M, Porto G, Duarte JA, Fernandes E (2012). "Trihydroxyflavones with antioxidant and anti-inflammatory efficacy". BioFactors38 (5): 378–386. doi:10.1002/biof.1033PMID 22806885

 Additional Literature

Landolt P.J, Phillips T.W. Host plant influences on sex pheromone behavior of phytophagous insects. Annu. Rev. Entomol. 1997; 42371-391   View in Article | Scopus (252) | PubMed | Crossref | Google Scholar

Nishida R. Sequestration of defensive substances from plants by Lepidoptera. Annu. Rev. Entomol. 2002; 4757-92  View in Article | Scopus (377) | PubMed | Crossref | Google Scholar

Conner W.F et al. Courtship pheromone production and body size as correlates of larval diet in males of the arctiid moth, Utethisa ornatrix. J. Chem. Ecol. 1990; 16543-552  View in Article | Scopus (73) | PubMed | Crossref | Google Scholar

Eisner T, Meinwald J. The chemistry of sexual selection. Proc. Natl. Acad. Sci. U. S. A. 1995; 9250-55  View in Article | Scopus (156) | PubMed | Crossref | Google Scholar

Hartmann T. Chemical ecology of pyrrolizidine alkaloids. Planta. 1999; 207483-495  View in Article | Scopus (201) | Crossref | Google Scholar

Lindigkeit R. et al. The two faces of pyrrolizidine alkaloids: the role of the tertiary amine and its N-oxide in chemical defense of insects with acquired plant alkaloids. Eur. J. Biochem. 1997; 245626-636  View in Article | Scopus (102) | PubMed | Crossref | Google Scholar

Winter C.K., Segall H.J. Metabolism of pyrrolizidine alkaloids. in: Cheeke P.R Toxicants of Plant Origin. Vol. 1. CRS PressBoca Raton, FL, USA198923-40  View in Article | Google Scholar

Naumann C. et al. Evolutionary recruitment of a flavin-dependent monooxygenase for the toxification of host-plant acquired pyrrolizidine alkaloids in the alkaloid-defended arctiid moth Tyria jacobaeae. Proc. Natl. Acad. Sci. U. S. A. 2002; 996085-6090/  View in Article | Scopus (87) | PubMed | Crossref | Google Scholar

Krasnoff S.B., Dussourd D.E. Dihydropyrrolizine attractants for arctiid moths that visit plants containing pyrrolizidine alkaloids. J. Chem. Ecol. 1989; 1547-60  View in Article | Scopus (44) | PubMed | Crossref | Google Scholar

Schulz S. Insect–plant interactions. Metabolism of plant compounds to pheromones and allomones by Lepidoptera and leaf beetles.

Eur. J. Org. Chem. 1998; 13-20  View in Article | Scopus (56) | Crossref | Google Scholar

Hartmann T et al. Are insect-synthesized retronecine esters (creatonotines) the precursors of the male courtship pheromone in the arctiid moth Estigmene acrea?. J. Chem. Ecol. 2003; 292603-2608  View in Article | Scopus (22) | PubMed | Crossref | Google Scholar

Dressler R.L. Biology of the orchid bees (Euglossini). Annu. Rev. Ecol. Syst. 1982; 13373-394  View in Article | Crossref | Google Scholar

Raina A.K. et al. Chemical signals from host plant and sexual behavior in a moth. Science. 1992; 255592-594  View in Article | Scopus (73) | PubMed | Crossref | Google Scholar

Byers J.A. Pheromone biosynthesis in the bark beetle, Ips paraconfusus, during feeding or exposure to vapors of host plant precursors. Insect Biochem. 1981; 11563-569  View in Article | Scopus (65) | Crossref | Google Scholar

Hunt D.W.A et al. Sex-specific production of ipsdienol and myrcenol by Dendroctonus ponderosae (Coleoptera: Scolytidae) exposed to myrcene vapors. J. Chem. Ecol. 1986; 121579-1586  View in Article | Scopus (33) | PubMed | Crossref | Google Scholar

Renwick J.A.A et al. Selective production of cis and trans-verbenol from (−)- and (+)-α-pinene by a bark beetle. Science. 1976; 191199-201  View in Article | Scopus (123) | PubMed | Crossref | Google Scholar

Feyereisen R. Insect P450 enzymes. Annu. Rev. Entomol. 1999; 44507-533  View in Article | Scopus (646) | PubMed | Crossref | Google Scholar

Seybold S.J et al. De novo biosynthesis of the aggregation pheromone components ipsenol and ipsdienol by the pine bark beetles Ips paraconfusus Lanier and Ips pini (Say) (Coleoptera: Scolytidae). Proc. Natl. Acad. Sci. U. S. A. 1995; 928393-8397  View in Article | Scopus (100) | PubMed | Crossref | Google Scholar

Tillman J.A et al. Endocrine regulation of the novo aggregation pheromone biosynthesis in the pine engraver Ips pini (Say) (Coleoptera: Scolytidae).

Insect Biochem. Mol. Biol. 1998; 28705-715  View in Article | Scopus (65) | Crossref | Google Scholar

Barkawi L.S et al. Frontalin: de novo biosynthesis of an aggregation pheromone component by Dendroctonus spp. bark beetles (Coleoptera: Scolytidae). Insect Biochem. Mol. Biol. 2003; 33773-788  View in Article | Scopus (47) | PubMed | Crossref | Google Scholar

Ivarsson P, Birgersson G. Regulation and biosynthesis of pheromone components in the double spined bark beetle Ips duplicatus (Coleoptera: Scolytidae). J. Insect Physiol. 1995; 41833-849  View in Article | Scopus (28) | Crossref | Google Scholar

Seybold S.J., Tittiger C. Biochemistry and molecular biology of de novo isoprenoid pheromone production in the Scolytidae. Annu. Rev. Entomol. 2003; 48425-453  View in Article | Scopus (85) | PubMed | Crossref | Google Scholar

Tittiger C et al. Structure and juvenile hormone-mediated regulation of the HMG-CoA reductase gene from the Jeffrey pine beetle, Dendroctonus jeffreyi. Mol. Cell. Endocrinol. 2003; 19911-21  View in Article | Scopus (42) | PubMed | Crossref | Google Scholar

Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 1990; 343425-430  View in Article | Scopus (4156) | PubMed | Crossref | Google Scholar

Dickens J.C. Green leaf volatiles enhance aggregation pheromone of the boll weevil Anthonomus grandis. Entomol. Exp. Appl. 1989; 52191-203  View in Article | Scopus (99) | Crossref | Google Scholar

Jaffe K. et al. Chemical ecology of the palm weevil Rhynchophorus palmarum (L.) (Coleoptera: Curculionidae): attraction to host plants and to a male-produced aggregation pheromone. J. Chem. Ecol. 1993; 191703-1720  View in Article | Scopus (86) | PubMed | Crossref | Google Scholar

Rochat D. et al. Identification of pheromone synergists in American weevil, Rhynchophorus palmarus, and attraction of related Dynamis borassi. J. Chem. Ecol. 2000; 26155-187  View in Article | Scopus (67) | Crossref | Google Scholar

McNeil J.N., Delisle J. Host plant pollen influences calling behavior and ovarian development of the sunflower moth, Homeosoma electellum. Oecologia. 1989; 80201-205  View in Article | Google Scholar |

Hendrikse A., Vos-Bunnemyer E. Role of host plant stimuli in sexual behavior of small ermine moths (Yponomeuta). Ecol. Entomol. 1987; 12363-371  View in Article | Scopus (34) | Crossref | Google Scholar

Landolt P.J., Heath R.R. Sexual role reversal in mate-finding strategies of the cabbage looper moth. Science. 1990; 2491026-1028  View in Article | Scopus (46) | PubMed | Crossref | Google Scholar

Nakamuta K. et al. Increase of trap catches by a combination of male sex pheromones and floral attractant in longhorn beetle, Anaglyptus subfasciatus. J. Chem. Ecol. 1997; 231635-1640  View in Article | Scopus (41) | Crossref | Google Scholar

Erbilgin N., Raffa K.F. Effects of host tree species on attractiveness of tunnelling pine engravers, Ips pini (Coleoptera: Scolytidae), to conspecifics and insect predators. J. Chem. Ecol. 2000; 26823-840  View in Article | Scopus (38) | Crossref | Google Scholar

Renwick J.A.A., Vité J.P. Bark beetle attractants: mechanism of colonization by Dendroctonus frontalis. Nature. 1969; 2241222-1223  View in Article | Scopus (99) | Crossref | Google Scholar

Reinecke A. et al. The scent of food and defense: green leaf volatiles and toluquinone as sex attractant mediate mate finding in the European cockchafer Melolontha melolontha. Ecol. Lett. 2002; 5257-263  View in Article | Scopus (41) | Crossref | Google Scholar

Reddy G.V.P et al. Olfactory responses of Plutella xylostella natural enemies to host pheromone, larval frass, and green leaf volatiles. J. Chem. Ecol. 2002; 28131-143  View in Article | Scopus (127) | PubMed | Crossref | Google Scholar

Reddy G.V.P., Guerrero A. Behavioral responses of the diamondback moth, Plutella xylostella, to green leaf volatiles of Brassica oleracea subsp. capitata. J. Agric. Food Chem. 2000; 486025-6029  View in Article | PubMed | Crossref | Google Scholar

Hayes J.L. et al. Repellent properties of the host compound 4-allylanisole to the southern pine beetle. J. Chem. Ecol. 1994; 201595-1615  View in Article | Scopus (55) | PubMed | Crossref | Google Scholar

Dickens J.C. et al. Green leaf volatiles interrupt aggregation pheromone response in bark infesting pines. Experientia. 1992; 48523-524  View in Article | Scopus (91) | Crossref | Google Scholar

De Groot P., MacDonald L.M.  Green leaf volatiles inhibit response of red pine cone beetle Conophthorus resinosae (Coleoptera: Scolytidae) to a sex pheromone. Naturwissenschaften. 1999; 8681-85  View in Article | Scopus (23) | Crossref | Google Scholar

Poland T.M., Haack R.A. Pine shoot beetle, Tomicus piniperda (Col., Scolytidae), responses to common green leaf volatiles. J. Appl. Entomol. 2000; 12463-69 View in Article | Scopus (40) | Crossref | Google Scholar

Huber D.P.W., Borden J.H. Angiosperm bark volatiles disrupt response of Douglas-fir beetle, Dendroctonus pseudotsugae, to attractant-baited traps. J. Chem. Ecol. 2001; 27217-233  View in Article | Scopus (53) | PubMed | Crossref | Google Scholar

Poland T.M. et al. Green leaf volatiles disrupt responses by the spruce beetle, Dendroctonus rufipennis, and the western pine beetle, Dendroctonus brevicomis (Coleoptera: Scolytidae) to attractant-baited traps. J. Entomol. Soc. B.C. 1998; 9517-24  View in Article | Google Scholar |

Guerrero A. et al. Semiochemically induced inhibition of behaviour of Tomicus destruens (Woll.) (Coleoptera: Scolytidae). Naturwissenschaften. 1997; 84: 155-157  View in Article | Scopus (38) | Crossref | Google Scholar

Thaler J.S. Jasmonate-inducible plant defenses cause increased parasitism of herbivores. Nature. 1999; 339686-688  View in Article | Scopus (414) | Crossref | Google Scholar

De Moraes C.M. et al. Caterpillar-induced nocturnal plant volatiles repel non-specific females. Nature. 2001; 410577-580  View in Article | Scopus (638) | PubMed | Crossref | Google Scholar

Erbilgin N., Raffa K.F. Modulation of predator attraction to pheromones of two prey species by stereochemistry of plant volatiles. Oecologia. 2001; 127444-453. View in Article | Scopus (66) | Crossref | Google Scholar

Raffa K.F., Klepzig K.D. Chiral escape of bark beetles from predators responding to a bark beetle pheromone. Oecologia. 1989; 80566-569  View in Article | Scopus (68) | Crossref | Google Scholar

Agrawal A.A. Mechanisms, ecological consequences and agricultural implications of tri-trophic interactions. Curr. Opin. Plant Biol. 2000; 3329-335  View in Article | Scopus (87) | PubMed | Crossref | Google Scholar

Takabayashi J., Dicke M. Plant–carnivore mutualism through herbivore-induced carnivore attractants. Trends Plant Sci. 1996; 1109-113  View in Article | Scopus (362) | Abstract | Full Text PDF | Google Scholar

Tumlinson J.H. et al. How parasitic wasps find their hosts. Sci. Am. 1993; 268100-106  View in Article | PubMed | Crossref | Google Scholar

Paré P.W., Tumlinson J.H. Plant volatiles as a defense against insect herbivores. Plant Physiol. 1999; 121325-331  View in Article | PubMed | Crossref | Google Scholar

Mattiacci L. et al. β-Glucosidase: an elicitor of herbivore-induced plant odor that attracts host-searching parasitic wasps. Proc. Natl. Acad. Sci. U. S. A. 1995; 922036-2040  View in Article | Scopus (434) | PubMed | Crossref | Google Scholar

Alborn H.T. et al. An elicitor of plant volatiles from beet armyworm oral secretion. Science. 1997; 276945-949  View in Article | Scopus (673) | Crossref | Google Scholar

Meiners T., Hilker M. Induction of plant synomones by oviposition of a phytophagous insect. J. Chem. Ecol. 2000; 26221-232  View in Article | Scopus (151) | Crossref | Google Scholar

Doss R.P. et al. Bruchins: insect-derived plant regulators that stimulate neoplasm formation. Proc. Natl. Acad. Sci. U. S. A. 2000; 976218-6223  View in Article | Scopus (157) | PubMed | Crossref | Google Scholar

Baldwin I.T. et al. Merging molecular and ecological approaches in plant-insect interactions. Curr. Opin. Plant Biol. 2001; 4351-358  View in Article | Scopus (148) | PubMed | Crossref | Google Scholar

Schittko U. et al. Eating the evidence? Manduca sexta can not disrupt specific jasmonate induction in Nicotiana attenuata by rapid consumption. Planta. 2000; 210343-346  View in Article | Scopus (84) | PubMed | Crossref | Google Scholar

Baldwin I.T. An ecologically motivated analysis of plant-herbivore interactions in native tobacco. Plant Physiol. 2001; 1271449-1458  View in Article | Scopus (177) | PubMed | Crossref | Google Scholar

Kahl H. et al. Herbivore-induced ethylene suppresses a direct defense but not a putative indirect defense against an adapted herbivore. Planta. 2000; 210336-342  View in Article | Scopus (257) | PubMed | Crossref | Google Scholar

Voelckel C. et al. Herbivore-induced ethylene burst reduces fitness costs of jasmonate- and oral secretion-induced defenses in Nicotiana attenuata. Oecologia. 2001; 127274-280  View in Article | Scopus (39) | PubMed | Crossref | Google Scholar

Kessler A., Baldwin I.T. Defensive function of herbivory-induced plant volatile emissions in nature. Science. 2001; 2912141-2144  View in Article | Scopus (1320) | PubMed | Crossref | | Google Scholar

Klein M.G. et al. Japanese beetle (Coleoptera: Scarabeidae): response to synthetic sex attractants plus phenethyl:eugenol. J. Chem. Ecol. 1981; 71-7  View in Article | Scopus (25) | PubMed | Crossref | Google Scholar

Lin H.L.P. et al. Synergism between synthetic food odors and the aggregation pheromone for attracting Carpophilus lugubris in the field (Coleoptera: Nitidulidae). Environ. Entomol. 1992; 21156-159  View in Article | Google Scholar 

Gries G. et al. Ethyl propionate: synergistic kairomone for African palm weevil, Rhynchophorus phoenicis L. (Coleoptera: Curculionidae). J. Chem. Ecol. 1994; 20889-897  View in Article | Scopus (45) | PubMed | Crossref | Google Scholar

Borden J.H. et al. Ethanol and α-pinene as synergists for the aggregation pheromones of two Gnathotrichus species. Can. J. Forest Res. 1980; 10290-292 View in Article | Crossref | Google Scholar

Ochieng S.A. et al. Host plant volatiles synergize responses of sex pheromone-specific olfactory receptor neurons in male Helicoverpa zea. J. Comp. Physiol. A. 2002; 188325-333  View in Article | Scopus (124) | Crossref | Google Scholar

Giblin-Davis R.M. et al. Optimization of semiochemical-based trapping of Metamasius hemipterus sericeus (Olivier) (Coleoptera: Curculionidae). J. Chem. Ecol. 1996; 221389-1410  View in Article | Scopus (41) | PubMed | Crossref | Google Scholar

Dowd P.F., Bartelt R.J. Host-derived volatiles as attractants and pheromone synergists for driedfruit beetle, Carpophilus hemipterus. J. Chem. Ecol. 1991; 17285-308  View in Article | Scopus (33) | PubMed | Crossref | Google Scholar

Phillips T.W. et al. Behavioral responses to food volatiles by two species of stored-product Coleoptera, Sitophilus oryzae (Curculionidae) and Tribolium castaneum (Tenebrionidae). J. Chem. Ecol. 1993; 19723-734  View in Article | Scopus (92) | PubMed | Crossref | Google Scholar

Rochat D. et al. Chemical ecology of palm weevils, Rhynchophorus spp. (Coleoptera). Oleagineux Paris. 1993; 48225-236  View in Article | Google Scholar

Giblin-Davis R.M. et al. Field response of Rhychophorus cruentatus (Coleoptera: Curculionidae) to its aggregation pheromone and fermenting plant volatiles. Florida Entomologist. 1994; 77164-177  View in Article | Scopus (53) | Crossref | Google Scholar

Bartelt R.J. et al. Male produced aggregation pheromone of Carpophilus freemani (Coleoptera: Nitidulidae). J. Chem. Ecol. 1993; 19107-118  View in Article | Scopus (35) | PubMed | Crossref | Google Scholar

Petroski R.J. et al. Male-produced aggregation pheromone of Carpophilus obsoletus (Coleoptera: Nitidulidae). J. Chem. Ecol. 1994; 201483-1493  View in Article | Scopus (18) | PubMed | Crossref | Google Scholar

Hallett R.H. et al. Pheromone trapping protocols for the Asian palm weevil, Rhynchophorus ferrugineus (Coleoptera: Curculionidae). Int. J. Pest Manage. 1999; 45231-237  View in Article | Scopus (72) | Crossref | Google Scholar |

Sudharto P.S. et al. Synergy between empty oil palm fruit bunches and synthetic aggregation pheromone (ethyl 4-methyloctanoate) for mass trapping of Oryctes rhinoceros beetles in the oil palm plantations in Indonesia. Cutting Edge Technologies for Sustained Competitiveness: Proceedings of the 2001 PIPOC International Palm Oil Congress. Malaysian Palm Oil BoardKuala Lumpur, Malaysia2000  View in Article | Google Scholar

Muniappan, R. et al. Field response of the two geographical isolates of New Guinea sugarcane weevil, Rhabdoscelus obscurus (Boisduval) (Coleoptera: Curculionidae) to their aggregation pheromone and host volatiles in Guam. Micronesica (in press). View in Article | Google Scholar

Bartelt R.J. et al. Aggregation pheromones in Drosophila borealis and Drosophila littoralis. J. Chem. Ecol. 1988; 141319-1327  View in Article | Scopus (26) | PubMed | Crossref | Google Scholar

Light D.M. et al. Host-plant green volatiles synergize the synthetic sex pheromones of the corn earworm and codling moth (Lepidoptera). Chemoecology. 1993; 4145-152  View in Article | Scopus (134) | Crossref | Google Scholar

Dickens J.C. et al. Detection and deactivation of pheromone and plant odor components by the beet armyworm, Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae). J. Insect Physiol. 1993; 39503-516  View in Article | Scopus (61) | Crossref | Google Scholar

Hardie J. et al. The interaction of sex pheromone and plant volatiles for field attraction of male bird-cherry aphid, Rhopalosiphum padi. Proceedings – Brighton Crop Protection Conference, Pests and Diseases. Vol. 3. BCPC PublicationsBracknell, UK1994  View in Article | Google Scholar

Phillips T.W. et al. Aggregation pheromone of the deodar weevil, Pissodes nemorensis (Coleoptera: Curculionidae): isolation and activity of grandisol and grandisal. J. Chem. Ecol. 1984; 101417-1423  View in Article | Scopus (45) | PubMed | Crossref | Google Scholar

Landolt P.J. et al. Attraction of female papaya fruit fly (Diptera: Tephritidae) to male pheromone and host fruit. Environ. Entomol. 1992; 211154-1159  View in Article | Google Scholar

Dickens J.C. et al. Green leaf volatiles enhance sex attractant pheromone of the tobacco budworm, Heliothis virescens (Lepidoptera: Noctuidae). Chemoecology. 1993; 4175-177  View in Article | Scopus (72) | Crossref | Google Scholar

Conner W.F. et al. Precopulatory sexual interaction in an arctiid moth (Utetheisa ornatrix): role of a pheromone derived from dietary alkaloids. Behav. Ecol. Sociobiol. 1981; 9227-235  View in Article | Scopus (142) | Crossref | Google Scholar

Seybold S.J. et al. The biosynthesis of coniferophagous bark beetle pheromones and conifer isoprenoids: evolutionary perspective and synthesis. Can. Entomol. 2000; 132697-753  View in Article | Scopus (96) | Crossref | Google Scholar

 

 Related Articles

· A Bidirectional Circuit Switch Reroutes Pheromone Signals in Male and Female Brains. Kohl et al. CellDecember 19, 2013  In Brief    Full-Text     PDF    Open Access

· Murine Pheromone Proteins Constitute a Context-Dependent Combinatorial Code Governing Multiple Social Behaviors. Kaur et al.  CellApril 24, 2014   In Brief   Full-Text   PDF    Open Archive

· Role of Polarized G Protein Signaling in Tracking Pheromone Gradients. McClure et al. Developmental CellNovember 23, 2015    In Brief  |  Full-Text   PDF   Open Archive

· Biochemical and genetic characterization of a competence pheromone from B. subtilis. Magnuson et al. CellApril 22, 1994. In Brief Full-Text PDF

· Yeast peptide pheromones, a-factor and α-factor, activate a common response mechanism in their target cells. Bender et al. CellDecember 26, 1986   In Brief   Full-Text  PDF

 

 

 

 

 

Home
Regon Technologies
RepelPerfection Technology
NanoFix Technology
EnerJazzy Technology
GeneENCODE Technology
Regon Pharmaceuticals - HomeAmazingCURE - Product PageBurnAWAY - Product PageColicAWAY - Product PageFresh & Beautiful - Product PageFluAWAY - Product PageFluAWAY - How It Works pagePainAWAY - Product PageWoundAWAY - Product Page